Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1994-12-22
1999-02-02
Loring, Susan A.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
4241841, 4242791, 4242821, 4242341, A61K 39085, A61K 3900, A61K 4500, A61K 3902
Patent
active
058661409
ABSTRACT:
A process is disclosed for culturing clinical Staphylococcus epidermidis cells that reproducibly enables identification of a limited number of predominant serotypes. Two predominant serotypes common to most clinical cases of S. epidermidis have been identified and are denoted Type I and Type II. A particular polysaccharide surface antigen is associated with each of the Type I and Type II serotypes. The surface antigens can be used to provide active and passive immunization against S. epidermidis infection and to produce a hyperimmune immunoglobulin or antibodies for treatment of S. epidermidis infection.
REFERENCES:
patent: 4197290 (1980-04-01), Yoshida
patent: 4902616 (1990-02-01), Fournier et al.
patent: 5055455 (1991-10-01), Pier
patent: 5097020 (1992-03-01), Anderson
Kijima et al., "Antibody to the Capsular Polysaccharide/Adhesin Protects Rabbits against Catheter-Related Bacteremia . . . ", Jnl. of Inf. Dis., 162:435-441 (1990).
Yoshida et al., "Isolation of an Encapsulated Strain of Staphylococcus epidermidis", The Society for Applied Bacteriology, 47:299-301 (1979).
Tojo et al., "Isolation and Characterization of a Capsular Polysaccharide Adhesin from Staphylococcus epidermis", Jnl. of Infectious Diseases, 157:713-722 (1988).
Archer, "Staphylococcus epidermis: The organism, its diseases, and treatment", Corr. Clin. Topics Infect. Dis., pp. 25-48 (1984).
Ichiman et al., "The Relationship of Capsular-type of Staphylococcus epidermis to Virulence and Induction . . . ", Jnl. of Applied Bacteriology, 51:229-241 (1981).
Ichiman et al., Jnl. of Applied Bacteriology, 71:176-181 (1991).
Ichiman et al., "Protective antibodies in human sera against encapsulated strains of Staphylococcus epidermis", Jnl. of Applied Bacteriology, 63:165-169 (1987).
Robbins et al., "Prevention of Invasive Bacterial Diseases by Immunization with Polysaccharide Protein Conjugates", Current Topics in Microbiology and Immunology, 146:169-180 (1989).
Nelles et al., Infect. Imm., 49:14-18 (1985).
Fattom et al., Infect. & Immunity, 58:2367-2374 (1990).
McDonald et al., "Immunochemical Analysis of a Uronic Acid Polymer of Staphylococcus epidermis, Strain 53", Jnl. of Immunology, 105:389-395 (1970).
Aasen, et al., Antigenic Studies on Staphylococcus Epidermidis, Acta path. microbiol. Scand. Section B, 79:827-834 (1971).
Johnsen, et al., Studies on Polysaccharide C of Staphylococcus Epidermidis Acta path. microbiol. scand. Sect. B. 83:226-234 (1975).
Johnsen, et al., Studies on Polysaccharide C of Staphylococcus Epidermidis Acta path. microbiol. scand. Sect. B. 83:235-239 (1975).
Hussain, et al., Comparison of cell-wall teichoic acid with high-molecular-weight extracellular slime material from Staphylococcus epidermidis, J. Moc. Microbiol. vol. 5:368-375 (1992).
Endl, et al., Chemical composition and structure of cell wall teichoic acids of staphylococci, Arch Microbiol. 135:215-223 (1983).
Fattom Ali Ibrahim
Karakawa, deceased Walter W.
Wright D. Craig
Loring Susan A.
Nabi
LandOfFree
Type I surface antigen associated with staphylococcus epidermidi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Type I surface antigen associated with staphylococcus epidermidi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Type I surface antigen associated with staphylococcus epidermidi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1114692